Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression

Human Immunology

Volumn 70, Issue 5, 2009, Pages 313-320

  Colvin, Bridget L ^a   Sumpter, Tina L ^a   Tokita, Daisuke ^a   Salati, Jennifer ^a   Mellor, Andrew L ^b   Thomson, Angus W ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; DNAX activating protein of 12 kDA; Indoleamine dioxygenase; Inducible costimulator ligand; T cells

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; INDUCIBLE COSTIMULATOR LIGAND; INTERLEUKIN 10; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; C57BL MOUSE; CELL ACTIVATION; CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME REGULATION; GENE SILENCING; GRAFT REJECTION; IMMUNOMODULATION; IMMUNOSTIMULATION; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL PROLIFERATION; DENDRITIC CELLS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEINS; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TRYPTOPHAN;

EID: 65049083279     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.01.021     Document Type: Article

References (54)

1. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9 (1991) 271-296
2. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
3. Colonna M., Trinchieri G., and Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat Immunol 5 (2004) 1219-1226
4. Shortman K., and Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7 (2007) 19-30
5. Wu L., and Liu Y.J. Development of dendritic-cell lineages. Immunity 26 (2007) 741-750
6. Fonteneau J.F., Gilliet M., Larsson M., Dasilva I., Munz C., Liu Y.J., et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 101 (2003) 3520-3526
7. Lou Y., Liu C., Kim G.J., Liu Y.J., Hwu P., and Wang G. Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses. J Immunol 178 (2007) 1534-1541
8. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
9. Morelli A.E., and Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7 (2007) 610-621
10. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., and Butcher E.C. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 9 (2008) 1253-1260
11. Young L.J., Wilson N.S., Schnorrer P., Proietto A., ten Broeke T., Matsuki Y., et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat Immunol 9 (2008) 1244-1252
12. Barchet W., Cella M., and Colonna M. Plasmacytoid dendritic cells-virus experts of innate immunity. Semin Immunol 17 (2005) 253-261
13. Bailey-Bucktrout S.L., Caulkins S.C., Goings G., Fischer J.A., Dzionek A., and Miller S.D. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 180 (2008) 6457-6461
14. Gilliet M., Cao W., and Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8 (2008) 594-606
15. Munn D.H., Sharma M.D., Hou D., Baban B., Lee J.R., Antonia S.J., et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114 (2004) 280-290
16. Goubier A., Dubois B., Gheit H., Joubert G., Villard-Truc F., Asselin-Paturel C., et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29 (2008) 464-475
17. Abe M., Wang Z., de Creus A., and Thomson A.W. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am J Transplant 5 (2005) 1808-1819
18. Ochando J.C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 7 (2006) 652-662
19. Fugier-Vivier I.J., Rezzoug F., Huang Y., Graul-Layman A.J., Schanie C.L., Xu H., et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med 201 (2005) 373-383
20. Ito T., Yang M., Wang Y.H., Lande R., Gregorio J., Perng O.A., et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 204 (2007) 105-115
21. Nurieva R., Thomas S., Nguyen T., Martin-Orozco N., Wang Y., Kaja M.K., et al. T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J 25 (2006) 2623-2633
22. Tesciuba A.G., Shilling R.A., Agarwal M.D., Bandukwala H.S., Clay B.S., Moore T.V., et al. ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes. J Immunol 181 (2008) 1019-1024
23. Burmeister Y., Lischke T., Dahler A.C., Mages H.W., Lam K.P., Coyle A.J., et al. ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol 180 (2008) 774-782
24. Mellor A.L., Chandler P., Baban B., Hansen A.M., Marshall B., Pihkala J., et al. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int Immunol 16 (2004) 1391-1401
25. Mellor A.L., Baban B., Chandler P., Marshall B., Jhaver K., Hansen A., et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 171 (2003) 1652-1655
26. Fallarino F., Vacca C., Orabona C., Belladonna M.L., Bianchi R., Marshall B., et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int Immunol 14 (2002) 65-68
27. Munn D.H., Sharma M.D., Lee J.R., Jhaver K.G., Johnson T.S., Keskin D.B., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297 (2002) 1867-1870
28. Fallarino F., Asselin-Paturel C., Vacca C., Bianchi R., Gizzi S., Fioretti M.C., et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 173 (2004) 3748-3754
29. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A., et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 9 (2002) 1069-1077
30. Grohmann U., Fallarino F., Bianchi R., Belladonna M.L., Vacca C., Orabona C., et al. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J Immunol 167 (2001) 708-714
31. Grohmann U., Fallarino F., Silla S., Bianchi R., Belladonna M.L., Vacca C., et al. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells. J Immunol 166 (2001) 277-283
32. Sharma M.D., Baban B., Chandler P., Hou D.Y., Singh N., Yagita H., et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 117 (2007) 2570-2582
33. Baban B., Hansen A.M., Chandler P.R., Manlapat A., Bingaman A., Kahler D.J., et al. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. Int Immunol 17 (2005) 909-919
34. Orabona C., Tomasello E., Fallarino F., Bianchi R., Volpi C., Bellocchio S., et al. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. Eur J Immunol 35 (2005) 3111-3118
35. Morelli A.E., Larregina A.T., Shufesky W.J., Zahorchak A.F., Logar A.J., Papworth G.D., et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101 (2003) 611-620
36. Brawand P., Fitzpatrick D.R., Greenfield B.W., Brasel K., Maliszewski C.R., and De Smedt T. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J Immunol 169 (2002) 6711-6719
37. Taner T., Hackstein H., Wang Z., Morelli A.E., and Thomson A.W. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant 5 (2005) 228-236
38. Hackstein H., Taner T., Zahorchak A.F., Morelli A.E., Logar A.J., Gessner A., et al. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101 (2003) 4457-4463
39. Raimondi G., Shufesky W.J., Tokita D., Morelli A.E., and Thomson A.W. Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells. J Immunol 176 (2006) 2808-2816
40. Manlapat A.K., Kahler D.J., Chandler P.R., Munn D.H., and Mellor A.L. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells. Eur J Immunol 37 (2007) 1064-1071
41. Orabona C., Belladonna M.L., Vacca C., Bianchi R., Fallarino F., Volpi C., et al. Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. J Immunol 174 (2005) 6582-6586
42. Mellor A.L., and Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4 (2004) 762-774
43. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3 (2002) 1097-1101
44. Fallarino F., Orabona C., Vacca C., Bianchi R., Gizzi S., Asselin-Paturel C., et al. Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int Immunol 17 (2005) 1429-1438
45. Orabona C., Puccetti P., Vacca C., Bicciato S., Luchini A., Fallarino F., et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107 (2006) 2846-2854
46. Abe M., Colvin B.L., and Thomson A.W. Plasmacytoid dendritic cells: in vivo regulators of alloimmune reactivity?. Transplant Proc 37 (2005) 4119-4121
47. Lau A.H., Abe M., and Thomson A.W. Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo. J Leukocyte Biol 79 (2006) 941-953
48. Lanier L.L., and Bakker A.B. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today 21 (2000) 611-614
49. Bakker A.B., Hoek R.M., Cerwenka A., Blom B., Lucian L., McNeil T., et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13 (2000) 345-353
50. Hamerman J.A., Tchao N.K., Lowell C.A., and Lanier L.L. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 6 (2005) 579-586
51. Sjolin H., Robbins S.H., Bessou G., Hidmark A., Tomasello E., Johansson M., et al. DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol 177 (2006) 2908-2916
52. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402 (1999) 827-832
53. Xu Y., Zhan Y., Lew A.M., Naik S.H., and Kershaw M.H. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 179 (2007) 7577-7584
54. Bluestone J.A., Thomson A.W., Shevach E.M., and Weiner H.L. What does the future hold for cell-based tolerogenic therapy?. Nat Rev Immunol 7 (2007) 650-654